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GOTTLIEB C. FRIESINGER, MD, FACC, RENU VIRMANI, MD
Nashville, Tennessee
To determine the relation between right ventricular hy-
pertrophy and right ventricular myocardial infarction
in patients with chronic lung disease, the records of 28
patients with chronic lung disease, inferior myocardial
infarction and significant coronary artery disease (group
I) and 20 patients with right ventricular hypertrophy,
chronic lung disease without inferior myocardial infarc-
tion or significant coronary artery disease (group II)
were reviewed. Chronic lung disease was diagnosed by
clinical criteria, chest radiographs and pulmonary func-
tion tests. All patients had postmortem examinations.
Patients in group I were classifiedinto two subgroups:
group la (without right ventricular hypertrophy) and
group Ib (with right ventricular hypertrophy). Right
ventricular waIl thickness was 3.3 mm ± 0.5 in group
la , 6.0 mm ± 1.1 in group Ib and 8.8 mm ± 2.4 in
group II (group la versus Ib, p < 0.001; group la versus
II, p < 0.001; group Ib versus II, p < 0.001). Eleven
patients (78.6%) in group Ib (chronic lung disease with
both right ventricular hypertrophy and inferior myo-
cardial infarction) had right ventricular myocardial in-
farction compared with only 3 patients (21.9%) in group
Right ventricular infarction is reported in 5 to 43% of pa-
tients with transmural inferior infarction of the left ventricle
when studied pathologically (1). Prospective clinical studies
(2-5) using echocardiographic and scintigraphic methods
have confirmed these pathologic observations . The occur-
rence of right ventricular myocardial infarction in patients
with chronic lung disease and right ventricular hypertrophy
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la (chronic lung disease without right ventricular hy-
pertrophy and with inferior myocardial infarction) (p <
0.008). Isolated right ventricular myocardial infarction
occurred in four patients (20%) in group II (chronic
lung disease with right ventricular hypertrophy, but
without evidence of infarction of the left ventricle or
significant coronary artery disease). There was no sig-
nificant difference in the extent of anatomic coronary
disease in groups Ia and lb. The cause of death was
believed to be directly related to right ventricular myo-
cardial infarction in 6 (33%) of 18 patients; 4 patients
were from group Ib and 2 from group II.
Patients with right ventricular hypertrophy as a re-
sult of chronic lung disease are prone to right ventricular
myocardial infarction in the setting of inferior myo-
cardial infarction. Isolated right ventricular myocardial
infarction may occur in patients with chronic lung dis-
ease, right ventricular hypertrophy and insignificant
coronary artery disease. Both increased myocardial ox-
ygen demand and a decreased supply may play a role
in this relation.
(J Am Coli Cardiol1985;5:1302-7)
has not been studied systematically and remains controver-
sial. Although early studies (6) suggested a possible role of
right ventricular hypertrophy in the pathogenesis of right
ventricular infarction, a large necropsy study by Isner et al.
(7) failed to show an association between these two entities.
The purpose of our study was to determine the relation
between right ventricular myocardial infarction and right
ventricular hypertrophy caused by chronic lung disease . We
retrospectively analyzed 28 patients with significant chronic
lung disease, coronary artery disease and a documented
transmural inferior myocardial infarction and 20 patients
with right ventricular hypertrophy secondary to chronic lung
disease but without evidence of inferior myocardial infarc-
tion or significant coronary artery disease. These patients
were studied for pathologic evidence of right ventricular
infarction and the clinical relevance of such an event.
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Methods
Study patients. The autopsy records at the Veterans
Administration Medical Center, Nashville, Tennessee dur-
ing the period from 1980 to 1983 were reviewed to select
patients with significant chronic lung disease. This diagnosis
was based on clinical and physical findings, history of heavy
cigarette smoking, biopsy-proven interstitial lung disease,
serial chest radiography and pulmonary function tests. All
patients with at least three of these five criteria were included
in the retrospective analysis. The diagnosis of significant
lung disease was confirmed pathologically at autopsy. The
majority of the patients selected had been followed up in a
cardiology or pulmonary subspecialty clinic with chronic
lung disease being their primary diagnosis.
Pathology. The hearts were evaluated for the presence
of right ventricular hypertrophy, defined as 5 mm or greater
right ventricular wall thickness uniformly measured at the
posterior wall of the right ventricle at the level of the inferior
border of the posterior tricuspid valve leaflet. Care was taken
to exclude papillary muscle in the measurement (8-11). This
method for evaluating right ventricular hypertrophy was
chosen over chamber partition and weight and area mea-
surements (12,13). In our experience, the epicardial fat is
often extensive over the anterior wall of the right ventricle
and it is not uniformly possible to separate fat from myo-
cardium. Epicardial fat infiltrates deeply into the myocar-
dium making mass measurements less accurate. Pathologic
evidence of inferior myocardial infarction (by gross and
microscopic examination) and the presence of significant
anatomic atherosclerotic coronary artery disease (defined as
75% or greater reduction in cross-sectional luminal area of
the epicardial coronary arteries after postmortem injection
of microvascular dye) were noted (14,15). Patients with
valvular heart disease, cardiomyopathy or vasculitis were
excluded.
Patient groups. On the basis of the criteria outlined,
the patients were classified as belonging to one of the fol-
lowing three groups: group la = chronic lung disease with-
out right ventricular hypertrophy and with inferior myo-
cardial infarction; group Ib = chronic lung disease with
both right ventricular hypertrophy and inferior myocardial
infarction; group II = chronic lung disease with right ven-
tricular hypertrophy but without evidence of infarction of
the left ventricular myocardium or significant anatomic ath-
erosclerotic coronary artery disease.
The presence or absence of right ventricular myocardial
infarction was then noted. Right ventricular myocardial in-
farction was classified using the pathologic grading system
of Isner and Roberts (7) (grade I = ~50% of the posterior
wall of the right ventricle; grade II = limited to the posterior
wall but involved ~50% of it; grade III = all of the posterior
wall and ~50% of the anterolateral wall; grade IV = all
of the posterior wall and ~50% of the anterolateral wall).
Medical records were reviewed for clincal data and rele-
vance of such an event without prior knowledge of autopsy
data.
Statistical analysis. Data analysis was performed using
Student's t test and the chi-square. Student t test was used
to compare relative right ventricular wall thickness between
groups. The chi-square was chosen to compare discontin-
uous variables, that is, incidence of severe coronary artery
disease (~2 vessel) and incidence of right ventricular myo-
cardial infarction. All results were expressed as mean and
standard deviation. A probability value of less than 0.05
was considered significant.
Results
Clinical findings (Table 1, Fig. 1). Forty-eight patients
were studied; all were male. There was no difference in age
(60 ± 10 years) or race in the three groups. Pulmonary
function testing was available in the compensated state within
6 months of death in 17 of these patients and results were
compatible with severe airways obstruction. The diagnosis
of significant chronic obstructive pulmonary disease was
confirmed in 43 patients who manifested at least three of
the criteria previously outlined. Of the remaining five pa-
tients, alphaj-antitrypsin deficiency was present in one and
restrictive lung disease in four patients. Diffusion capacity
and results of spirometric testing were consistent with severe
restrictive lung disease in those four patients (16,17).
Pathologic findings. Pathologic evidence confirming lung
disease was present in all 40 of the 48 patients with pul-
monary tissue available for study, manifested by severe
emphysematous changes or interstitial fibrosis. The relative
severity of lung disease among each of the three groups
could not be assessed by our postmortem techniques. Right
ventricular wall thickness was 3.3 mm ± 0.5 in group la
(chronic lung disease without right ventricular hypertrophy
and with inferior myocardial infarction), 6.0 mm ± 1.1 in
group Ib (chronic lung disease with right ventricular hy-
pertrophy and inferior myocardial infarction) and 8.8 mm
± 2.4 in group II (chronic lung disease with right ventricular
hypertrophy but without evidence of infarction of the left
ventricle or significant coronary artery disease). These val-
ues reached statistical significance: group la versus Ib, p <
0.001; group la versus II, p < 0.001; group Ib versus II,
p < 0.001 (Fig. 1).
Extent of anatomic atherosclerotic coronary artery dis-
ease present at autopsy (Table J). There was no significant
difference between groups la and Ib; however, group II
(chronic lung disease, inferior myocardial infarction with
right ventricular hypertrophy) had less coronary atheroscle-
rosis on the basis of experimental design, that is, none of
the patients in group II had significant anatomic coronary
atherosclerosis as defined previously.
Table 1. Characteristics of 48 Patients Studied
Group la Group Ib Group II
Age RV Severe Age RV Severe Age RV Severe
Case (yr) (mm) CAD RVMl Case (yr) (mm) CAD RVMl Case (yr) (mm) CAD RVMl
I 68 3.0 + + 15 59 5.0 + + 29 57 7 .0 - +
2 80 3.0 + + 16 63 5.0 - + 30 49 10.0
3 54 4 .0 + + 17 67 6.0 + + 31 53 10.0
4 84 4.0 - 18 60 6.0 + + 32 58 7.0
5 71 3.0 - - 19 64 6.0 - + 33 59 10.0
6 63 3.0 + - 20 63 5.0 + + 34 38 12.0
7 41 3.0 + - 21 57 6.0 + + 35 57 12.0
8 60 3.0 - - 22 54 6.0 + + 36 82 10.0
9 73 2.0 + 23 61 5.0 + + 37 29 12.0
10 73 3.0 + - 24 65 7 .0 + + 38 63 6 .0
II 66 3.0 + - 25 64 5.0 + + 39 33 11.0
12 47 4.0 - - 26 63 9.0 + - 40 60 6.0
13 54 4.0 + 27 51 7.0 + - 4 1 67 7.0 - +
14 70 4.0 + - 28 73 6.0 - - 42 46 11.0
Total 65 ± 11 3.3 ± 0 .5 10114 3/14 62 ± 5 6.0 ± 1.1* 11/14 11114* 43 52 5.0
44 58 8.0
45 58 5.0
46 53 11.0 - +
47 76 6.0
48 56 10.0 - +
56 ± 10 8.8 ± 2.4t 0120 4/20
*p < 0 .008, K = 7.0 (group Ia vs. Ib; tp < 0 .008 , K = 7.0 (group Ia vs. II, group Ib vs. II). Group la = chronic lung disease without right ventricu lar hypertrophy
and with inferior myocardial infarction ; group Ib = chronic lung disease with both right ventricu lar hypertrophy and inferior myocardial infarction; group II = chronic
lung disease with right ventricular hypertrophy, but without infarction of the left ventricle or significant coronary artery disease . RV = right ventricular thickness ; RVMI
= right ventricular myocardial infarction ; Severe CAD = coronary artery disease with ~75% cross-sectional area luminal narrowing by atherosclerosis involving ~2
vessels ; + = positive or present; - = negative or absent .
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Figure 1. A, Right ventricular wall thickness in three groups of
patients. Group la = chronic lung disease without right ventricular
hypertrophy and with inferior myocardial infarction; group Ib =
chronic lung disease with both right ventricular hypertrophy and
inferior myocardial infarction; group II = chronic lung disease
with right ventricular hypertrophy, but without infarction of the
leftventricle or significant coronary artery disease (*group Ib ver-
susgroup la, p < 0.001; **group II versus group Ib, p < 0.001).
B, Incidence of right ventricular myocardial infarction (tgroup Ib
versus groups la and II, p < 0.008, K = 7.0).
Incidence of right ventricular infarction in each of the
groups (Table I, Fig. 1). A total of 18 right ventricular
myocardial infarctions were identified; 15 were classified
as grade I and 3 were classifed as grade III. Of the latter,
two occurred in group Ib patients and one in a group II
patient. Patients with inferior myocardial infarction and right
ventricular hypertrophy (group Ib) had a significantlyhigher
incidence of right ventricular infarction compared with pa-
tients with inferior infarction but without hypertrophy of the
right ventricle (group la) (11 versus 3, p < 0.008, Y =
7.0). There was no significant difference between groups
la and II in the incidence of right ventricular infarction (three
versus four; p = NS).
Significance of right ventricular infarction (Table
2). The cause of death was considered directly related to
acute right ventricular infarction in 6 (33%) of 18 patients;
4 were from group Ib and 2 from group II. Three had grade
III right ventricular infarction and three had grade I. None
of the right ventricular infarctions occurring in group la
appeared to be directly related to the patient's death. Two
of the six patients with right ventricular infarction died im-
mediately after coronary artery bypass surgery (both were
in group Ib). Patient 25 could not be weaned from the
cardiopulmonary bypass pump. The surgeon noted the right
ventricle to be dilated and hypocontractile in comparison
with a vigorously contracting left ventricle. Patient 18 ex-
periencedcardiovascular collapse immediately after surgery
and could not be resuscitated. At postmortem examination,
a large, acute, grade III right ventricular infarction was
documented. One patient (Case 24) experienced rupture of
the right ventricular posterior wall and cardiac tamponade.
The other three patients (Cases 15, 19, 48) experienced
refractory cardiogenic shock in the setting of acute right
ventricular infarction without other explanation for their
death.
Discussion
We recently reported a patient (Case 48) with severe
restrictive lung disease and right ventricular hypertrophy
who died after an isolated grade III right ventricular in-
farction (18). This led us to investigate whether patients
with right ventricular hypertrophy and decreased pulmonary
vascular reserve were at increased risk for right ventricular
infarction in the setting of an inferior infarction. In this
Table 2. Characteristics of Six Patients Who Died as a Direct Result of Right Ventricular
Myocardial Infarction
Age Grade RVMI RV Severe
Case (yr) Group (mm) (mm) CAD Comments
48 56 II III 10.0 Cardiogenic shock
29 57 II I 7.0 Cardiogenic shock
25 64 lb I 5.0 + Coronary artery
bypass surgery
18 60 Ib III 6.0 + Coronary artery
bypass surgery
24 65 Ib 7.0 + Right ventricular
posterior wall
rupture and
cardiac tamponade
15 59 Ib 1lI 5.0 + Cardiogenic shock
Abbreviations as inTable I.
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study, right ventricular hypertrophy was associated with a
significantly higher incidence of right ventricular infarction.
This occurred despite a lack of difference in anatomic coro-
nary artery disease demonstrable at necropsy and the pres-
ence of transmural inferior myocardial infarction in all 28
patients. The similar extent of anatomic coronary artery
obstruction is noteworthy in light of potential differences in
collateral blood flow and role of the moderator band artery
in determining right ventricular infarct size (19). We also
observed that the incidence of right ventricular infarction in
patients with right ventricular hypertrophy due to chronic
lung disease, but without significant anatomic coronary ar-
tery disease (group II), was similar to the incidence in those
with chronic lung disease and inferior myocardial infarction
but without right ventricular hypertrophy (group la) . The
patients in group II had isolated right ventricular infarction
thought to be quite rare (1,20). There was no pathologic
evidence of mural thrombus in the left atrium or ventricle
of these patients , and histologic sections of the coronary
artery did not show evidence of vasculitis. To our knowl-
edge, this is the first report of right ventricular infarction in
patients with chronic lung disease and right ventricular hy-
pertrophy without significant anatomic coronary artery disease.
Pathologic studies on right ventricular infarction.
Since Wade 's necropsy report (6) of II patients with right
ventricular infarction in 1959, much attention has been fo-
cused on this entity, leading to extensive clinical investi -
gation both before and after death. It appears that isolated
right ventricular infarction is rare, with an incidence rate
ranging from l.7 to 3.0% in large autopsy series (1,20) .
However, infarction of the right ventricle is common in
patients with left ventricular inferior infarction (average 19%,
range 5 to 43) (1,7,14). The incidence of right ventricular
infarction in group la of our study (21.4%) is consistent
with scintigraphic (21) and pathologic data previously cited .
However, its incidence in group Ib (78 .6%) is much higher
than might be expected from other studies.
Several characteristics ofpatients dying from right ven-
tricular infarction have been identified. There is a high
frequency of concurrent inferior left ventricular wall in-
farction, particularly involving the posterior interventricular
septum (7). In addition , most patients have at least a 75%
reduction in cross-sectional area of the dominant coronary
artery supplying the inferior left ventricular wall (7,13).
The association of right ventricular myocardiaL infarc-
tion with chronic Lung disease and right ventricular hyper-
trophy remains controversial. Wade (6) reported an in-
creased incidence of chronic lung disease , right ventricular
hypertrophy and systemic hypertension in patients with
pathologic right ventricular infarction. Isner and Roberts (7)
were unable to confirm these findings; they noted an as-
sociation between right ventricular dilation and right ven-
tricular infarction. Horan et al. (13) demonstrated a strong
correlation between right ventricular hypertrophy and right
ventricular area, the latter an index of right ventricular di-
lation . Horan and his coworkers referred to these measures
of increased right ventricular mass as right ventricular en-
largement. They noted 15 patients with gross pathologic
right ventricular infarction; 11 of them met criteria for right
ventricular enlargement.
Role of right ventricular hypertrophy. In an attempt
to investigate the role of right ventricular mass and pressure
in the pathogenesis of right ventricular infarction, Ratliff
et al. (22) developed a porcine model with pulmonary hy-
pertension and right ventricular hypertrophy by banding the
main pulmonary artery trunk. An ameroid constrictor was
applied to the right coronary artery to produce infarction of
the inferior wall of the left ventricle. These investigators
demonstrated a marked increase in susceptibility to right
ventricular infarction in pigs with right ventricular hyper-
trophy due to pressure overload compared with control
animals.
Possible pathogenetic mechanisms. Most patients with
chronic obstructive lung disease of moderate severity (forced
expiratory volume in 1 second and forced vital capacity
65% of predicted) have only a mild increase in pulmonary
pressure and pulmonary vascular resistance at rest (23). It
may be that transient nocturnal oxygen desaturation (24) or
exercise (23) , or both, leads to more severe pulmonary
hypertension and overt cor pulmonale in some patients with
chronic obstructive pulmonary disease . In the patient with
cor pulmonale, chronically elevated afterload leads to an
increase in right ventricular mass and abnormal compliance.
Coronary insufficiency may become manifest in the setting
of increased right ventricular mass where a decrease in coro-
nary reserve may already exist. Extravascular compressive
forces, owing to the increased mass of the right ventricle
and elevated right ventricular filling pressure, may contrib-
ute to ischemia. Since patients with chronic obstructive pul-
monary disease routinely have high negative intrathoracic
pressures , this may further compromise coronary blood flow
(25 ,26). Ultimately, it may be that right ventricular hyper-
trophy in patients with chronic lung disease is a " marker"
for patients who are at risk for developing the clinical syn-
drome of acute right ventricular infarction, particularly in
the setting of transmural inferior myocardial infarction.
Implications. Right ventricular infarction contributes to
serum enzyme estimates of infarct size among patients with
inferior transmural myocardial infarction and probably ac-
counts for a better prognosis than patients with anterior
infarction and similar enzyme elevations (27-29) . In our
study, death directly related to right ventricular infarction
occurred in 33%. This high mortality rate may be the result
of selection bias, the retro spective nature of the study or
the relatively small number of patients. However, because
death directly related to right ventricular infarction occurred
only in groups Ib and II, it is reasonable to assume that
increased right ventricular mass is the explanation.
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